|
|
|
|
|
|
|
|
|
24.06.26 - 13:15
|
Ohne Entwicklungshilfe werden die deutschen Krankenhäuser sterben (Tichys Einblick)
|
|
|
Das Absturzrisiko Nr. 1 für den gewöhnlichen Deutschen scheint inzwischen nicht mehr Alkohol, Arbeitslosigkeit oder Alleinerziehung zu sein, sondern das falsche Kreuz auf dem Wahlzettel. Das wird derzeit kaum irgendwo deutlicher als bei der von verantwortungsloser Politik verursachten Implosion sowohl der Wirtschaft als auch der sozialen Sicherungssysteme. Damit sind genau diejenigen Bürger vom Kollaps der
Der Beitrag Ohne Entwicklungshilfe werden die deutschen Krankenhäuser sterben erschien zuerst auf Tichys Einblick....
|
|
|
|
|
|
|
|
|
24.06.26 - 01:00
|
China′s biotech surge sparks US security concerns as drug trials break records in 2025 (SCMP)
|
|
|
Clinical drug trial registrations in China hit a record last year, the country's drug regulator said, with more than 5,000 trials reported in the latest sign of the nation's growing pipeline of novel drug candidates.
The total number of clinical drug trials reached 5,215 in 2025, more than double the figure recorded in 2020, according to a report released by the National Medical Products Administration on Monday.
Of those, 57.5 per cent were trials for new drugs, an 18 per cent year-on-year......
|
|
|
|
|
|
|
|
|
|
|
23.06.26 - 19:06
|
How Eli Lilly′s CEO Plans to Defeat Pharma′s Boom-Bust Cycle (Bloomberg)
|
|
|
When Dave Ricks became chief executive officer of Eli Lilly & Co. in 2017, he was facing an industry under siege.
Americans held drug companies in lower esteem than airlines, law firms and even the federal government. President Donald Trump, then starting his first term, was excoriating them for their high prices. A mounting number of reports showed that soaring costs were even forcing some diabetics to ration insulin. Ricks, the 11th CEO in Lilly's 150-year history, concedes that one was a public-relations nightmare.
Almost a decade later, the mood at Lilly has shifted dramatically. The company's hit diabetes shot, Mounjaro, and obesity shot, Zepbound, have transformed its fortunes and, in many ways, its public image. We speak with Madison Muller, Bloomberg News Healthcare Reporter, for a closer look. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23.06.26 - 06:00
|
How AI integration into real-world tasks enhances healthcare and education (SCMP)
|
|
|
The growing use of artificial intelligence (AI) in our daily lives has become a constant topic of worldwide conversation. Its most proclaimed everyday benefits of the technology include boosting efficiency, productivity and decision-making, but developing and deploying it is a much more complicated matter.
The next phase of its adoption will be defined not by access to the technology, but by the ability to translate AI capabilities into real-world outcomes. In education and healthcare,......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
